The DOI matches its Crossref record.
BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model
Abstract
Purpose: The BRCAPRO model, used to predict a family's likelihood of carrying a BRCA1 or BRCA2 mutation, was designed using mutation frequencies of white and Ashkenazi Jewish populations, and may not be applicable to other populations. BRCAPRO was recently validated in African Americans, although has yet to be examined in Hispanics. This retrospective study reports the mutation frequency and spectrum of BRCA1 and BRCA2 mutations in a Hispanic population and evaluates the BRCAPRO model in Hispanics. Patients and Methods: A descriptive analysis of mutation frequency and spectrum was performed for Hispanic patients who underwent BRCA1 and BRCA2 genetic testing at a single institution. For comparative analysis of the BRCAPRO risk model, Hispanic patients who underwent comprehensive analysis were compared with white controls using area under the receiver operating characteristic curves (AUROC). Results: Fourteen Hispanic individuals who underwent comprehensive analysis were identified to carry a mutation in BRCA1 or BRCA2 (17.9%; 95% CI, 10.2% to 28.3%) and seven individuals had a variant of uncertain significance (9.0%; 95% CI, 12.0% to 30.8%). A total of eight different mutations and three variants were observed within the entire Hispanic population. When evaluating the performance of the BRCAPRO model, the AUROC for Hispanics was 0.774 (95% CI, 0.63 to 0.90), compared with the AUROC of 0.770 (95% CI, 0.65 to 0.89) for whites. Conclusion: Deleterious BRCA1 and BRCA2 mutations occur at considerable frequency within the Hispanic population, many of which have been identified previously in other ethnic populations. The BRCAPRO model appears to perform equally well in Hispanics as in whites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RealRisks uses this data to run the BRCAPRO model, which calculates the patient’s personalized five-year breast cancer risk, lifetime breast cancer risk, and probability of carrying a BRCA1/2 mutation [48, 49].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 40
- 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z · DOI · Paper page
- 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P · doi:10.1002/(sici)1097-0142(20000315)88:6<1393::aid-cncr17>3.0.co;2-p
- 10.1002/cncr.21536 · DOI · Paper page
- 10.1093/jnci/91.11.943 · DOI · Paper page
- 10.1086/318787 · DOI · Paper page
- 10.1086/301749 · DOI · Paper page
- 10.1200/JCO.2005.03.6772 · DOI · Paper page
- 10.1126/science.1088759 · DOI · Paper page
- 10.1002/humu.10260 · DOI · Paper page
- 10.1200/JCO.2002.20.6.1480 · DOI · Paper page
- 10.1001/jama.294.15.1925 · DOI · Paper page
- 10.1001/jama.1997.03550150046034 · DOI · Paper page
- 10.1038/sj.ejhg.5200717 · DOI
- Baudi F, Quaresima B, Grandinetti C, et al: Evidence of a founder mutation of in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat 18:163,2001-164, BRCA1 · DOI
- 10.1002/ijc.1627 · DOI
- 10.1007/s004390050895 · doi:10.1007/s004390050895
- 10.1002/humu.10154 · DOI
- 10.1186/bcr1282 · DOI
- Ruiz-Flores P, Sinilnikova OM, Badzioch M, et al: and mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 20:474,2002-475, BRCA1 BRCA2 · doi:10.1002/humu.9084
- Sarantaus L, Auranen A, Nevanlinna H: and mutations among Finnish ovarian carcinoma families. Int J Oncol 18:831,2001-835, BRCA1 BRCA2 · doi:10.3892/ijo.18.4.831
- Sng JH, Ali AB, Lee SC, et al: c. 2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer. Ann Acad Med Singapore 32:S53,2003-S55, BRCA1 · DOI
- Armstrong K, Weber B, Stopfer J, et al: Early use of clinical testing: Associations with race and breast cancer risk. Am J Med Genet A 117:154,2003-160, BRCA1/2 · DOI
- 10.1001/jama.293.14.1729 · DOI · Paper page
- 10.1007/s00439-004-1240-5 · DOI
- 10.1002/cncr.11533 · DOI
- 10.1158/1055-9965.EPI-05-0072 · doi:10.1158/1055-9965.epi-05-0072
- 10.1200/JCO.2005.02.2368 · DOI
- 10.1200/JCO.2002.05.121 · DOI · Paper page
- 10.1086/301670 · DOI · Paper page
- 10.1093/bioinformatics/bti623 · DOI · Paper page
- Blesa JR, Garcia JA, Ochoa E: Frequency of germ-line mutations among Spanish families from a Mediterranean area. Hum Mutat 15:381,2000-382, BRCA1 · doi:10.1002/(sici)1098-1004(200004)15:4<381::aid-humu14>3.0.co;2-h
- Osorio A, Robledo M, Martinez B, et al: Molecular analysis of the gene in 16 breast/ovarian cancer Spanish families. Clin Genet 54:142,1998-147, BRCA2 · doi:10.1111/j.1399-0004.1998.tb03717.x
- 10.1038/ng1095-198 · DOI · Paper page
- 10.1093/jnci/89.3.227 · DOI · Paper page
- 10.1046/j.1524-4741.2001.20012.x · DOI
- 10.1200/JCO.2006.05.5889 · DOI · Paper page
- 10.1093/jnci/94.11.844 · DOI
- 10.1002/cncr.11434 · doi:10.1002/cncr.11434
- Parmigiani G, Chen S, Iversen E, et al: Validity of models for prediction of and mutations. Ann Intern Med (in press)BRCA1 BRCA2
- 10.1093/jnci/93.11.824 · DOI · Paper page
Cited by
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, T. R., Friebel, T. M., Friedman, E., Hamann, U., Huo, D., Kwong, A., Olah, E., Olopade, O. I., Solano, A. R., Teo, S.-H., et al. (2018) · Human Mutation · doi:10.1002/humu.23406 · Cited by 312
Self-citationPrevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
Mersch, J., Brown, N., Pirzadeh-Miller, S., Mundt, E., Cox, H. C., Brown, K., Aston, M., Esterling, L., Manley, S., & Ross, T. (2018) · JAMA · doi:10.1001/jama.2018.13152 · Cited by 268
YI, B.-R., CHOI, K. J., KIM, S. U., & CHOI, K.-C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1523 · Cited by 32
“Variable risk factors for breast cancer include gender, age, female hormone exposure, ethnicity, obesity, family history of breast cancer, genetic risk factors, and many abnormal conditions of the breast (13,14).”
BackgroundSilverman, T. B., Vanegas, A., Marte, A., Mata, J., Sin, M., Ramirez, J. C. R., Tsai, W.-Y., Crew, K. D., & Kukafka, R. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3442-x · Cited by 19
Metadata
- Authors
- Vogel, K. J., Atchley, D. P., Erlichman, J., Broglio, K. R., Ready, K. J., Valero, V., Amos, C. I., Hortobagyi, G. N., Lu, K. H., & Arun, B.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-10-10
- Volume
- 25
- Issue
- 29
- Pages
- 4635-4641
- ISSN
- 0732-183X
- 1527-7755
- Cited by
- 52
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.